Search

Site news

The problem with user accounts expiring has been fixed.  If you are having any problems logging in please contact us.
Historic graphs are now available.
Health Sentinel news now appears on google news - check news.google.com
The problem with e-mail an article has now been fixed.

Over 100 original articles on health and other topics such as the environment and the economy are now available.

Fight World Hunger
Home
Ginkgo Protects the Liver and Kidneys from Uranium PDF Print E-mail
(6 votes, average 4.00 out of 5)
Written by Roman Bystrianyk   
Saturday, 13 March 2010 03:10
ginkgoDating back to over 200 million years, ginkgo biloba is considered the oldest tree species on earth, with ginkgo trees having been known to live over an average of 1,000 years or more. Ginkgo has been shown to possess antioxidant activity and to aid in the prevention and treatment of diseases associated with free radicals. The two groups of significant compounds found in ginkgo are flavonoids, such as myricetin and quercitin, which provide for the antioxidant action, and terpenes which help inhibit the formation of blood clots. These compounds decrease the injury that occurs due to free radicals. Studies have also shown that the toxic liver damage of acetaminophen, also commonly known as Tylenol, is reduced through the antioxidant effects of ginkgo.

Uranium is a radioactive element that is present in the environment from uranium mining, nuclear industry emissions, military applications, through the use of coal and other fuels, by the use of phosphate fertilizers, and as a result of being slowly released from natural deposits. Uranium is both radioactive and toxic with the liver and kidneys being the main targets of uranium's toxic effects and with reservoirs of Uranium concentrating in the kidneys and bones. Uranium ends up in the human body through eating or drinking it or by inhaling dust particles containing uranium.

A new study in Journal of Medicinal Food evaluates the ginkgo's role in protecting the body from the toxic effects of uranium on the principal targets of the liver and kidneys. The study authors examined mice exposed to uranium with some mice treated with varying amounts of ginkgo.

Last Updated on Saturday, 13 March 2010 03:21
Read more...
 
Commentary: Nuclear Energy is Bad for our Children and Our Economy PDF Print E-mail
(8 votes, average 4.38 out of 5)
Written by Alice Shabecoff   
Saturday, 06 March 2010 12:34
nuclearPresident Obama, in his State of the Union speech, called for a push to build new nuclear power plants to help serve our country's energy needs. This is a truly unwise strategy. We'd go from the frying pan into the fire.

At the very time of the President's speech, a group of Vermonters were out in the snow and freezing cold, calling for the state's sole nuclear plant, the Vermont Yankee, to shut down. Their protest was ignited by revelations of rising levels of the radioactive element called tritium leaking from the plant into nearby water sources.

One of our closest friends, unfailingly honorable and intensely smart, is a nuclear engineer. He says that nuclear power can be safe if the right safeguards are put in place.

Let's say that might be so.

But what makes anyone imagine that the right safeguards could actually be developed and then maintained, day in and day out, for decades, if not eons.

Last Updated on Saturday, 06 March 2010 12:49
Read more...
 
Ghostbusting in Paxil Birth Defect Litigation PDF Print E-mail
(3 votes, average 5.00 out of 5)
Written by Evelyn Pringle   
Wednesday, 03 March 2010 16:31

ghostwritingA month before the first Paxil birth defect trial against GlaxoSmithKline was set to begin, the Associated Press ran the headline, "Glaxo Used Ghostwriting Program to Promote Paxil," in reporting on a program called "CASPPER," which allowed doctors to "take credit for medical journal articles mainly written by company consultants."

"Drug companies frequently hire outside firms to draft a manuscript touting a company's drug, retain a physician to sign off as the author and then find a publisher to unwittingly publish the work," the Associated Press said on August 19, 2009. "Drug company salespeople often present medical journal articles to physicians as independent proof that their drugs are safe and effective."

Between 2000 and 2002, articles from the CASPPER program appeared in five medical journals. On August 21, 2009, Jim Edwards on BNET, described the CASSPER ghostwriting brochure. The document shows that the intent of CASSPER was to flood the market with ghostwritten information, he said. It stated: "Paxil Product Management has budgeted for 50 articles for 2000."

The trial in Kilker v Glaxo ended on October 13, 2009, with a jury in Philadelphia finding that Glaxo "negligently failed to warn" the doctor treating Lyam Kilker's mother about Paxil's risks and the drug was a "factual cause" of Lyam's heart defects. The family was award $2.5 million.

Ghostwriting 101

The world-renowned neuropsychopharmacologist from the UK, Dr David Healy, testified as an expert witness for the plaintiffs in the Kilker trial.

While testifying, Healy explained the process of ghostwriting to the jury. He said ghostwriting probably began seriously in the 1980s. "It's where an article appears under the name of usually a fairly distinguished person in the field," he testified.

Last Updated on Wednesday, 03 March 2010 16:58
Read more...
 
Patient Survival Improved with CoQ10 and Antioxidants PDF Print E-mail
(10 votes, average 4.70 out of 5)
Written by Roman Bystrianyk   
Friday, 26 February 2010 13:20

antioxidantsFree radicals are atoms or groups of atoms with an unpaired number of electrons that are created in our bodies when oxygen interacts with molecules. These highly reactive radicals can then begin a chain reaction causing damage. The main hazard comes from the damage free radicals can do when they react with the cell's DNA or membrane and this injury may eventually lead to cancer. Antioxidants stabilize free radicals and may prevent some of the damage free radicals may otherwise cause.

A recent study in The Journal of International Medical Research examined 41 patients with end-stage cancer who were put on a supplemental nutritional treatment protocol. End-stage is considered the last phase of a disease and has replaced the somewhat less bleak term of terminal. The patients included in the study had solid tumors some of which were in the breast, brain, lungs, kidneys, pancreas, ovaries, and skin and who were also diagnosed with distant metastases. The authors explain the basis of the study as follows:

"Reactive oxygen species are able to activate all stages of carcinogenesis [creation of cancer]. Simplified, this process can be regarded as a continuous growth and accumulation of mutations in a cellular clone. If combinations of antioxidants have a preventive effect, it would seem possible that they would also retard the process at a later stage, i.e. when the cancer is apparent."

"There are several putative [commonly accepted] mechanisms for the potential anticancer effect of antioxidants. Most important among these are possible effects on cytokines, and inflammation, modulation of the expression of the tumour suppressor gene p53, inhibition of mutations, and inhibition of tumour angiogenesis [formation of blood vessels to the tumor]."

Last Updated on Friday, 26 February 2010 13:36
Read more...
 
Menomune - One Mother's Harrowing Experience with the Meningitis Vaccine PDF Print E-mail
(72 votes, average 4.40 out of 5)
Written by Virginia Young   
Saturday, 20 February 2010 03:07
marie2Well another Super Bowl has come and gone. People rushed the grocery stores in preparation for the big day. I ran up to the store just as the game was starting for a few more ingredients I needed for dinner. No surprise the place was empty. Other than staff only three customers were there at a time when the place should have been hopping, and I was one of them.

Chips, dips, beer were all purchased and the fans were snug in their living rooms with friends and family anxiously glued to the television sets. In all honesty watching the Super Bowl, while once an item on my to do list, has taken a back seat to something more important. For the last nine years Super Bowl Sunday has been a reminder to me to give thanks for my life and those who are special to me because nine years ago on Super Bowl Sunday my little girl fought for her life while the rest of the world watched football.

In 2001 news reports revealed several students had died from meningitis. Kelsey Seybold, a large clinic system located in Houston Texas, opened up clinics all around the Houston area. Every night we turned on the television to see reporters at these sites. Long lines of people were waiting their turn for the Menomune vaccine. We continued to hear reports of meningitis in the local schools. A teacherʼs husband had contracted it and it was not known whether or not he would live. Parents started pulling their children from class to take them to the doctor for the new vaccine.

I believed my children had reacted to their childhood immunizations although I could not find a physician to agree. Regardless, I was not clamoring for more. Then rumors spread of possible cases just a mile from our home. My husband was growing more concerned as his pregnant patients came into contact with the bug through friends and family. He called the Department of Health to inquire about the vaccine. He was told it was absolutely safe and he could use it in his pregnant patients.

Last Updated on Saturday, 20 February 2010 15:35
Read more...
 
Paxil Birth Defect Litigation - First Trial A Bust For Glaxo PDF Print E-mail
(5 votes, average 5.00 out of 5)
Written by Evelyn Pringle   
Monday, 15 February 2010 23:49

pharmacynightGlaxoSmithKline has paid out close to $1 billion to resolve lawsuits involving Paxil since the drug came on the market in1992, according to a December 14, 2009 Bloomberg report. But the billion dollars does not cover the more than 600 Paxil birth defect cases currently pending in multi-litigation in Pennsylvania.

Glaxo has settled about 10 birth defect cases, according to Sean Tracey, a Houston attorney who represented the family of a child victim in the first jury trial that decided in favor of the plaintiff on October 13, 2009, Bloomberg reports. The settlements in those lawsuits averaged about $4 million, people familiar with the cases told the new service.

First Trial A Bust for Glaxo

The first trial, in the case of Kilker v Glaxo, ended with a jury in Philadelphia finding that Glaxo "negligently failed to warn" the doctor treating Lyam Kilker's mother about Paxil's risks and the drug was a "factual cause" of Lyam's heart defects. The jury awarded the family $2.5 million in compensatory damages.

Last Updated on Tuesday, 16 February 2010 00:03
Read more...
 
A Medical Doctors' Open Letter Opposing the McCain Sponsored Dietary Supplement Safety Act (DSSA) PDF Print E-mail
(33 votes, average 4.64 out of 5)
Written by Nicholas J. Gonzalez, M.D.   
Monday, 08 February 2010 00:01
supplementsintrashDear Senator McCain:

Though I am a resident of New York, not Arizona, I suggest that someone in your staff read my letter very carefully as I believe you are unwittingly sponsoring a bill with potentially onerous consequences, one that might if I read the information about it properly, lead to the death of hundreds of my patients fighting advanced, terminal cancer. I do not think, if I am correct in my interpretation, that you would want their death on your conscience.

As some background, I am a registered Republican, and in the past have donated many thousands to Republican causes including your re-election, even when it became clear to me the Party, including you, had strayed significantly from its mission of limited government, deficit reduction, and ultimately, protection of individual liberty. In terms of my professional activities, I am a former journalist (Time Inc), currently a physician and cancer researcher, who educated at three Ivy League schools (Brown undergraduate, Columbia post grad, Cornell for medical school). I finished a fellowship in cancer immunology under Robert A. Good, for ten years President of Sloan-Kettering, and the most published author in the history of medicine. Under Dr. Good's direction, 29 years ago I began researching the use of diet, nutrients, and proteolytic enzymes against advanced cancer.

Last Updated on Monday, 08 February 2010 11:44
Read more...
 
Academic Bias and Fraud: The cases of bone marrow transplantation for breast cancer, and HIV-nevirapine. PDF Print E-mail
(21 votes, average 4.86 out of 5)
Written by Nicholas J. Gonzalez, M.D.   
Friday, 05 February 2010 03:25

nihFrom 1998 to 2005, my colleague Dr. Linda Isaacs and I worked closely with physicians and scientists from Columbia University, the National Cancer Institute (NCI), and the National Center for Complementary and Alternative Medicine (NCCAM), developing and pursuing a formal clinical trial comparing our nutritional approach to chemotherapy in patients diagnosed with inoperable pancreatic cancer. When the project first began we were excited by, and grateful for, this opportunity to have our therapy tested under what we hoped would be rigorous academic supervision. In a personal sense, the project represented the culmination of nearly 15 long years of our own research efforts, and our battles to have our therapy properly evaluated and eventually mainstreamed. We also hoped that in a more global sense, our particular clinical trial would help usher in a new era of cooperation between mainstream academic institutions, and serious alternative practitioners with promising new treatments. Indeed, in those long ago days as the project first began, we truly believed that the endless and fruitless war between mainstream medicine and more alternative approaches might finally be coming to an end, to everyone's benefit.

From the outset, the project generated praise and enthusiasm in the alternative press, as well as considerable interest in more mainstream venues such as the New Yorker Magazine,(1) but also some dismissive attacks. At times, we both felt we were in the middle of a firestorm. Nonetheless, whatever the obstacles we were determined to soldier on, prove to the scientific community the seriousness of our research efforts, and show once and for all that a treatment developed outside the academic world could come under scrutiny and be vindicated.

Last Updated on Sunday, 07 February 2010 19:13
Read more...
 
« StartPrev12345678910NextEnd »

Page 2 of 21

Graphs

graphs

News Flashback

Climate change is causing the tropics to widen, with possible impacts on the global food supply, research suggests. Scientists examined five different measures of the width of the tropical belt, and found it expanded by between 2 and 4.8 degrees latitude...

Read more...

Did you know?

“The direct medical costs associated with ADEs have been estimated to be in the range of $US30 billion to $US130 billion annually in the US alone. These estimates are even more meaningful when compared with other high cost conditions or diseases,...

Read more...

Who's Online

We have 110 guests online